Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen

Details 詳細情報について

• CRID

  1360016870444367744

• DOI

  10.1007/s00280-022-04492-6

• ISSN

  14320843

  03445704

• Web Site

  https://link.springer.com/content/pdf/10.1007/s00280-022-04492-6.pdf

  https://link.springer.com/article/10.1007/s00280-022-04492-6/fulltext.html

• Data Source

  • Crossref